[Form 4] Silence Therapeutics Plc American Depository Share Insider Trading Activity
Silence Therapeutics plc (SLN) 鈥� Form 4 insider buying
10% owner Richard Ian Griffiths, via Cream Capital Ltd., disclosed open-market purchases on 21-22 Jul 2025 of 25,345 American Depositary Shares (ADS) at $6.04 and $6.09. Each ADS converts into three ordinary shares, increasing his indirect holding by roughly 76,035 ordinary shares.
Post-trade, Griffiths鈥� beneficial position totals 鈮�11.78 million ADS-equivalent shares. No sales were reported. Continued accumulation by a 10% holder generally signals confidence in the company鈥檚 outlook and may support sentiment toward SLN shares.
Silence Therapeutics plc (SLN) 鈥� Acquisto da parte di un insider (Modulo 4)
Richard Ian Griffiths, detentore del 10% tramite Cream Capital Ltd., ha comunicato acquisti sul mercato aperto effettuati tra il 21 e il 22 luglio 2025 di 25.345 American Depositary Shares (ADS) a $6,04 e $6,09. Ogni ADS 猫 convertibile in tre azioni ordinarie, incrementando cos矛 la sua partecipazione indiretta di circa 76.035 azioni ordinarie.
Dopo le operazioni, la posizione beneficiaria di Griffiths ammonta a un totale di circa 11,78 milioni di azioni equivalenti ADS. Non sono state segnalate vendite. Un accumulo continuativo da parte di un azionista con il 10% di partecipazione generalmente indica fiducia nelle prospettive della societ脿 e pu貌 influenzare positivamente il sentiment verso le azioni SLN.
Silence Therapeutics plc (SLN) 鈥� Compra de insider seg煤n Formulario 4
Richard Ian Griffiths, propietario del 10% a trav茅s de Cream Capital Ltd., inform贸 compras en el mercado abierto los d铆as 21 y 22 de julio de 2025 de 25,345 American Depositary Shares (ADS) a $6.04 y $6.09. Cada ADS se convierte en tres acciones ordinarias, aumentando su participaci贸n indirecta en aproximadamente 76,035 acciones ordinarias.
Tras la operaci贸n, la posici贸n beneficiaria de Griffiths suma un total de 鈮�11.78 millones de acciones equivalentes a ADS. No se reportaron ventas. La acumulaci贸n continua por parte de un titular del 10% generalmente indica confianza en las perspectivas de la empresa y puede respaldar el sentimiento hacia las acciones de SLN.
Silence Therapeutics plc (SLN) 鈥� 雮措秬鞛� 毵れ垬 鞁犼碃靹�(Form 4)
10% 歆�攵� 氤挫湢鞛愳澑 Richard Ian Griffiths臧� Cream Capital Ltd.毳� 韱淀暣 2025雲� 7鞗� 21鞚缄臣 22鞚检棎 25,345 氙戈淡鞓堩儊歃濎劀(ADS)毳� 臧侁皝 $6.04鞕赌 $6.09鞐� 瓿店皽 鞁滌灔鞐愳劀 毵れ垬頄堧嫟瓿� 瓿奠嫓頄堨姷雼堧嫟. 臧� ADS電� 氤错喌欤� 3欤茧 鞝勴櫂霅橂┌, 攴胳潣 臧勳爲 氤挫湢 歆�攵勳澊 鞎� 76,035 氤错喌欤�毵岉伡 歃濌皜頄堨姷雼堧嫟.
瓯半灅 頉� Griffiths鞚� 鞁れ 氤挫湢 歆�攵勳潃 齑� 鞎� 1,178毵� ADS 靸侂嫻 欤检嫕鞐� 雼暕雼堧嫟. 毵る弰電� 氤搓碃霅橃 鞎婌晿鞀惦媹雼�. 10% 歆�攵� 氤挫湢鞛愳潣 歆�靻嶌爜鞚� 毵れ垬電� 鞚茧皹鞝侅溂搿� 須岇偓 鞝勲鞐� 雽�頃� 鞁犽毳� 雮橅儉雮措┌ SLN 欤检嫕鞐� 雽�頃� 韴瀽 鞁Μ毳� 歆�歆�頃� 靾� 鞛堨姷雼堧嫟.
Silence Therapeutics plc (SLN) 鈥� Achat d鈥檌niti茅 selon le formulaire 4
Richard Ian Griffiths, d茅tenteur de 10% via Cream Capital Ltd., a d茅clar茅 des achats sur le march茅 libre les 21 et 22 juillet 2025 de 25 345 American Depositary Shares (ADS) 脿 6,04 $ et 6,09 $. Chaque ADS se convertit en trois actions ordinaires, augmentant ainsi sa participation indirecte d鈥檈nviron 76 035 actions ordinaires.
Apr猫s la transaction, la position b茅n茅ficiaire de Griffiths s鈥櫭﹍猫ve 脿 environ 11,78 millions d鈥檃ctions 茅quivalentes ADS. Aucune vente n鈥檃 茅t茅 signal茅e. Une accumulation continue par un d茅tenteur de 10% indique g茅n茅ralement une confiance dans les perspectives de l鈥檈ntreprise et peut soutenir le sentiment envers les actions SLN.
Silence Therapeutics plc (SLN) 鈥� Insider-Kauf gem盲脽 Formular 4
Richard Ian Griffiths, ein 10%-Eigent眉mer 眉ber Cream Capital Ltd., meldete am 21. und 22. Juli 2025 offene Markt-K盲ufe von 25.345 American Depositary Shares (ADS) zu Preisen von $6,04 und $6,09. Jede ADS l盲sst sich in drei Stammaktien umwandeln, wodurch sein indirekter Anteil um etwa 76.035 Stammaktien steigt.
Nach dem Handel bel盲uft sich Griffiths鈥� wirtschaftliches Interesse auf insgesamt 鈮�11,78 Millionen ADS-盲quivalente Aktien. Verk盲ufe wurden nicht gemeldet. Eine fortgesetzte Ansammlung durch einen 10%-Anteilseigner signalisiert in der Regel Vertrauen in die Unternehmensperspektiven und kann die Stimmung gegen眉ber SLN-Aktien st眉tzen.
- 10% owner increased position by 25,345 ADS (~76k ordinary shares), demonstrating confidence.
- No shares were sold, eliminating mixed signals and underscoring a net accumulation stance.
- None.
Insights
TL;DR: Major shareholder adds 25k ADS, modest dollar outlay but positive signal of confidence.
The purchases expand Griffiths鈥� stake by ~0.2%, costing about US$154k. While immaterial to ownership concentration, insider buying by a long-term 10% holder often reassures investors about near-term prospects and valuation (SLN recently traded near 52-week lows). No derivative complexity or sales dilute the signal. Impact is supportive rather than transformative but leans positive.
Silence Therapeutics plc (SLN) 鈥� Acquisto da parte di un insider (Modulo 4)
Richard Ian Griffiths, detentore del 10% tramite Cream Capital Ltd., ha comunicato acquisti sul mercato aperto effettuati tra il 21 e il 22 luglio 2025 di 25.345 American Depositary Shares (ADS) a $6,04 e $6,09. Ogni ADS 猫 convertibile in tre azioni ordinarie, incrementando cos矛 la sua partecipazione indiretta di circa 76.035 azioni ordinarie.
Dopo le operazioni, la posizione beneficiaria di Griffiths ammonta a un totale di circa 11,78 milioni di azioni equivalenti ADS. Non sono state segnalate vendite. Un accumulo continuativo da parte di un azionista con il 10% di partecipazione generalmente indica fiducia nelle prospettive della societ脿 e pu貌 influenzare positivamente il sentiment verso le azioni SLN.
Silence Therapeutics plc (SLN) 鈥� Compra de insider seg煤n Formulario 4
Richard Ian Griffiths, propietario del 10% a trav茅s de Cream Capital Ltd., inform贸 compras en el mercado abierto los d铆as 21 y 22 de julio de 2025 de 25,345 American Depositary Shares (ADS) a $6.04 y $6.09. Cada ADS se convierte en tres acciones ordinarias, aumentando su participaci贸n indirecta en aproximadamente 76,035 acciones ordinarias.
Tras la operaci贸n, la posici贸n beneficiaria de Griffiths suma un total de 鈮�11.78 millones de acciones equivalentes a ADS. No se reportaron ventas. La acumulaci贸n continua por parte de un titular del 10% generalmente indica confianza en las perspectivas de la empresa y puede respaldar el sentimiento hacia las acciones de SLN.
Silence Therapeutics plc (SLN) 鈥� 雮措秬鞛� 毵れ垬 鞁犼碃靹�(Form 4)
10% 歆�攵� 氤挫湢鞛愳澑 Richard Ian Griffiths臧� Cream Capital Ltd.毳� 韱淀暣 2025雲� 7鞗� 21鞚缄臣 22鞚检棎 25,345 氙戈淡鞓堩儊歃濎劀(ADS)毳� 臧侁皝 $6.04鞕赌 $6.09鞐� 瓿店皽 鞁滌灔鞐愳劀 毵れ垬頄堧嫟瓿� 瓿奠嫓頄堨姷雼堧嫟. 臧� ADS電� 氤错喌欤� 3欤茧 鞝勴櫂霅橂┌, 攴胳潣 臧勳爲 氤挫湢 歆�攵勳澊 鞎� 76,035 氤错喌欤�毵岉伡 歃濌皜頄堨姷雼堧嫟.
瓯半灅 頉� Griffiths鞚� 鞁れ 氤挫湢 歆�攵勳潃 齑� 鞎� 1,178毵� ADS 靸侂嫻 欤检嫕鞐� 雼暕雼堧嫟. 毵る弰電� 氤搓碃霅橃 鞎婌晿鞀惦媹雼�. 10% 歆�攵� 氤挫湢鞛愳潣 歆�靻嶌爜鞚� 毵れ垬電� 鞚茧皹鞝侅溂搿� 須岇偓 鞝勲鞐� 雽�頃� 鞁犽毳� 雮橅儉雮措┌ SLN 欤检嫕鞐� 雽�頃� 韴瀽 鞁Μ毳� 歆�歆�頃� 靾� 鞛堨姷雼堧嫟.
Silence Therapeutics plc (SLN) 鈥� Achat d鈥檌niti茅 selon le formulaire 4
Richard Ian Griffiths, d茅tenteur de 10% via Cream Capital Ltd., a d茅clar茅 des achats sur le march茅 libre les 21 et 22 juillet 2025 de 25 345 American Depositary Shares (ADS) 脿 6,04 $ et 6,09 $. Chaque ADS se convertit en trois actions ordinaires, augmentant ainsi sa participation indirecte d鈥檈nviron 76 035 actions ordinaires.
Apr猫s la transaction, la position b茅n茅ficiaire de Griffiths s鈥櫭﹍猫ve 脿 environ 11,78 millions d鈥檃ctions 茅quivalentes ADS. Aucune vente n鈥檃 茅t茅 signal茅e. Une accumulation continue par un d茅tenteur de 10% indique g茅n茅ralement une confiance dans les perspectives de l鈥檈ntreprise et peut soutenir le sentiment envers les actions SLN.
Silence Therapeutics plc (SLN) 鈥� Insider-Kauf gem盲脽 Formular 4
Richard Ian Griffiths, ein 10%-Eigent眉mer 眉ber Cream Capital Ltd., meldete am 21. und 22. Juli 2025 offene Markt-K盲ufe von 25.345 American Depositary Shares (ADS) zu Preisen von $6,04 und $6,09. Jede ADS l盲sst sich in drei Stammaktien umwandeln, wodurch sein indirekter Anteil um etwa 76.035 Stammaktien steigt.
Nach dem Handel bel盲uft sich Griffiths鈥� wirtschaftliches Interesse auf insgesamt 鈮�11,78 Millionen ADS-盲quivalente Aktien. Verk盲ufe wurden nicht gemeldet. Eine fortgesetzte Ansammlung durch einen 10%-Anteilseigner signalisiert in der Regel Vertrauen in die Unternehmensperspektiven und kann die Stimmung gegen眉ber SLN-Aktien st眉tzen.
FAQ
How many SLN ADS did Richard Ian Griffiths buy?
What was the purchase price for the SLN insider transactions?
How many ordinary shares do the new ADS represent?
What is Richard Ian Griffiths鈥� total beneficial ownership after the trades?
Is the Form 4 purchase considered a positive signal for SLN investors?
